ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,024
Screening encounters
3,451
Diagnostic referrals
654
Outstanding pathways
243

Screening pathway

  1. Screening3,451Encounters
  2. Positive finding1,182Documented findings
  3. Referral654Diagnostic referrals
  4. Follow-up770Diagnostic visits
  5. Outcome411Resolved pathways

Stage totals use different units. Pending pathways: 243. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3796 · EXP-3796Synthetic · Site A

Full participant history through 2026-06-25, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2027-05-22

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3649 · Expanded synthetic participant 3649Site B — Peri-Urban Access Programme
EXP-3652 · Expanded synthetic participant 3652Site A — Urban Referral Hub
EXP-3656 · Expanded synthetic participant 3656Site A — Urban Referral Hub
EXP-3661 · Expanded synthetic participant 3661Site C — Rural Outreach Programme
EXP-3662 · Expanded synthetic participant 3662Site A — Urban Referral Hub
EXP-3663 · Expanded synthetic participant 3663Site C — Rural Outreach Programme
EXP-3664 · Expanded synthetic participant 3664Site A — Urban Referral Hub
EXP-3665 · Expanded synthetic participant 3665Site E — Resource-Constrained Navigation Programme
EXP-3666 · Expanded synthetic participant 3666Site A — Urban Referral Hub
EXP-3667 · Expanded synthetic participant 3667Site E — Resource-Constrained Navigation Programme
EXP-3669 · Expanded synthetic participant 3669Site C — Rural Outreach Programme
EXP-3670 · Expanded synthetic participant 3670Site E — Resource-Constrained Navigation Programme
EXP-3671 · Expanded synthetic participant 3671Site B — Peri-Urban Access Programme
EXP-3672 · Expanded synthetic participant 3672Site A — Urban Referral Hub
EXP-3674 · Expanded synthetic participant 3674Site B — Peri-Urban Access Programme
EXP-3676 · Expanded synthetic participant 3676Site E — Resource-Constrained Navigation Programme
EXP-3677 · Expanded synthetic participant 3677Site A — Urban Referral Hub
EXP-3678 · Expanded synthetic participant 3678Site B — Peri-Urban Access Programme
EXP-3679 · Expanded synthetic participant 3679Site B — Peri-Urban Access Programme
EXP-3682 · Expanded synthetic participant 3682Site D — Community Engagement Programme
EXP-3685 · Expanded synthetic participant 3685Site C — Rural Outreach Programme
EXP-3687 · Expanded synthetic participant 3687Site C — Rural Outreach Programme
EXP-3689 · Expanded synthetic participant 3689Site B — Peri-Urban Access Programme
EXP-3691 · Expanded synthetic participant 3691Site B — Peri-Urban Access Programme
EXP-3692 · Expanded synthetic participant 3692Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1384
HPV DNA
1565
Cytology
502

Navigation activity

Barrier documented
558
Contact attempt
964
Navigation intervention
241
Diagnostic booking
812
Diagnostic visit
770

Documented barriers

Contact difficulty
182
Transport difficulty
174
Appointment coordination
202

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.